Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Bullboard Posts
Comment by Insightful1on Apr 17, 2020 12:04pm
117 Views
Post# 30922176

RE:RE:RE:RE:RE:RE:Spain?

RE:RE:RE:RE:RE:RE:Spain?All companies are for profit, not just Sanitas. Your comments on Sanitas are naive, Sanitas is an insurer, they are looking to save money it is not a profit center per se.

If you catch a Stage 1 melanoma it saves the insurance company money. A Stage 1 melanoma costs $2,000 and a Stage 4 melanoma cost $150,000 a year per patient.

3,000 scans is a lot of scans and COVID-19 has shut down all Doctor to patient contact globally. So it is a bit early to call the patient DOA.

You should be pleased, according to your March 12th post you were  conveniently sitting in cash, gold and only own MedX shares. TheMedX  share price at that time was $.08 and is now at $.14 so maybe you were hoping MedX share price would perform as well as you cash?? 

Thanks and I hope this helps you with your understanding.
Bullboard Posts